Daniel E. Wolf, P.C.

During the course of his career, Daniel has worked on hundreds of M&A matters across geographies, industries and transaction types.

Public Company Representations Since 2015

• Bristol Myers Squibb in its $90 billion acquisition of Celgene and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen
• Danaher Corporation in its $21 billion acquisition of Biopharma business of General Electric and its $4 billion acquisition of Cepheid
• Bristol Myers Squibb in its $13.1 billion acquisition of MyoKardia
• Oak Street Health in its $10.6 billion sale to CVS Health
• Datto in its $6.2 billion sale to Kaseya 
• Swift Transportation in its $6 billion stock-for-stock merger with Knight Transportation
• Bristol Myers Squibb in its $5.8 billion acquisition of Mirati Therapeutics
• Abbott in its $5.8 billion acquisition of Alere
• Cvent in its $4.6 billion sale to Blackstone
• Travelport Worldwide in its $4.4 billion sale to Siris Capital and Elliott Management
• Bristol Myers Squibb in its $4.1 billion acquisition of Turning Point Therapeutics 
• Ping Identity in its $2.8 billion sale to Thoma Bravo
• Special Committee of Board of Directors of FGL Holdings in its $2.7 billion acquisition by Fidelity National Financial
• Ventas in its $1.75 billion acquisition of Ardent Medical Services
• Celator Pharmaceuticals in its $1.5 billion sale to Jazz Pharmaceuticals
• Del Frisco’s Restaurant Group in its $650 million sale to L Catterton
• Special Committee of the Board of Directors of MSC Industrial Supply in connection with MSC’s dual-class reclassification transaction with its controlling shareholders

Cross-Border Transactions Since 2015

• Teva Pharmaceutical in its $40.5 billion acquisition of Allergan Generics and U.S. antitrust clearance, which includes the largest ever drug divestiture in a pharmaceutical merger involving sales to 11 different buyers for an aggregate of approximately $1.7 billion, and its $500 million acquisition of Anda, a drug distribution business
• NortonLifeLock in its ~$25 billion combination with Avast
• Mead Johnson Nutrition in its $18 billion sale to Reckitt Benckiser plc
• GlaxoSmithKline in its $12.7 billion joint venture with Pfizer to combine their consumer health businesses
• Grubhub in its $7.3 billion sale to Just Eat Takeaway.com
• Misys Limited, a UK-based portfolio company of Vista Equity Partners, in its $4.8 billion take-private and combination with Canada-based financial technology firm DH Corporation
• JBT Corporation in its proposed €3.5 billion acquisition of Icelandic company Marel
• Renesas Electronics in its $2 billion supply agreement and cash deposit with Wolfspeed
• Mazor Robotics of Israel in its $1.6 billion sale to Medtronic plc
• Acorda Therapeutics in its $363 million acquisition of Finnish company Biotie Therapies

Contested Situations Since 2015

• Baxalta in connection with Shire plc’s unsolicited takeover bid resulting in a $32 billion sale
• Akzo Nobel in its successful defense of an unsolicited $28 billion takeover attempt by PPG Industries and activism led by Elliott Management
• Special Committee of Board of Directors of Verso Corporation in response to an unsolicited takeover bid and subsequent $825 million sale to BillerudKorsnäs
• Wyndham Hotels & Resorts in its successful defense of a $7.8 billion hostile takeover and full slate proxy contest by Choice Hotels International
• HanesBrands in connection with its cooperation agreement with Barington
• Clear Channel Outdoor in its cooperation agreement with Legion Partners
• Huntsman Corporation in its successful defense of a proxy contest by Starboard Value 
• Advance Auto Parts in its agreement with Starboard Value relating to board composition and leadership changes
• The Vitamin Shoppe in its defense of a proxy contest by a 13D group of hedge fund shareholders
• Avis Budget Group in its implementation of a poison pill after expiration of a cooperation agreement with SRS Investment and subsequent proxy contest
• Heron Therapeutics in connection with a cooperation agreement with Rubric Capital and Velan Capital
• Tenet Healthcare in its settlement agreement with Glenview Capital Management regarding a withdrawn bylaw proposal and Glenview’s support for Tenet’s board nominees

Carve-out and Spin-off Transactions Since 2015

• Celanese Corporation in its $11 billion acquisition of DuPont’s Mobility & Materials business and its $1.15 billion acquisition of ExxonMobil’s Santoprene TPV elastomers business
• Wyndham Worldwide in its spin-off of its ~ $11 billion hotel business to create two separate publicly traded hospitality companies, $1.95 billion acquisition of La Quinta Inns & Suites’ franchise and management businesses and approximately $1.3 billion sale of its European vacation rental business to Platinum Equity
• Verizon in its $5 billion sale of Verizon Media to funds managed by affiliates of Apollo Global Management
• Bristol Myers Squibb in its $3 billion divestiture of its HIV pipeline to ViiV Healthcare and its $1.6 billion sale of its French over-the-counter drugs business to Taisho Pharmaceutical
• ABB in the $2.9 billion sale of its Dodge mechanical power transmission division to RBC Bearings Incorporated
• Carvana in its $2.2 billion acquisition of ADESA’s U.S. physical auction business from KAR Global 
• Shenandoah Telecommunications Company (Shentel) in the $1.95 billion sale of its wireless business to T-Mobile USA
• Colfax Corporation in its $1.8 billion sale of its Air and Gas Handling business to KPS Capital Partners
• Vista Equity Partners in its $1.55 billion acquisition of the Advisory Board Company’s education business and $1.2 billion sale of the communities and sports division of ACTIVE Network to Global Payments
• John Bean Technologies (JBT) in the $800 million sale of its AeroTech Business to Oshkosh Corporation

Private Equity Sponsor Transactions Since 2015

• Vista Equity Partners in multiple take-privates, including its $16.5 billion acquisition of Citrix Systems, $4.6 billion acquisition of KnowBe4, $4 billion acquisition of EngageSmart, $3.5 billion acquisition of Pluralsight, $2.6 billion acquisition of Duck Creek Technologies, $2 billion acquisition of Apptio, $1.7 billion acquisition of Cvent and $1.25 billion acquisition of Model N
• Blackstone Group in its $2.3 billion acquisition of Rover, as majority stockholder of Invitation Homes in its $11 billion merger with Starwood Waypoint Homes, $6.1 billion acquisition of TeamHealth and $820 million PIPE investment in NCR Corporation
• Hellman & Friedman in its $10.2 billion acquisition of Zendesk  
• A consortium led by CC Capital in its $6.9 billion acquisition of Dun & Bradstreet
• Stone Point Capital in its $6 billion acquisition of CoreLogic
• Clayton, Dubilier & Rice in its $5.8 billion acquisition of Cornerstone Building Brands
• Patient Square Capital in its $890 million acquisition of Radius Health and in its consortium acquisition of Syneos Health for approximately $7.1 billion

Private Company Transactions Since 2015

• Danaher Corporation in its $9.6 billion acquisition of Aldevron
• Colfax Corporation in its $3.2 billion acquisition of DJO Global
• Bristol Myers Squibb in its $2.1 billion acquisition of Cardioxyl Pharmaceuticals, $1.25 billion acquisition of Flexus Biosciences, $1.25 billion acquisition of Promedior and $520 million acquisition of Cormorant Pharmaceuticals
• Fortive Corporation in its $2 billion acquisition of Accruent, $1.425 billion acquisition of Provation Software and $570 million acquisition of Intelex Technologies
• Websense in its $1.9 billion sale to Raytheon
• Waters Corporation in its $1.36 billion acquisition of Wyatt Technology
• Gerson Lehrman Group in the investment by SFW Capital of $212 million
• Grubhub in its acquisitions of Tapingo, LevelUp and Eat24
• Sard Verbinnen in its merger with Finsbury Glover Hering